ISSN: 0093-7754

Journal Home

Journal Guideline

Seminars in Oncology Q1 Unclaimed

W.B. Saunders Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Seminars in Oncology is a journal indexed in SJR in Hematology and Oncology with an H index of 130. It has an SJR impact factor of 1,773 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1) Oncology (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

1,773

SJR Impact factor

130

H Index

56

Total Docs (Last Year)

192

Total Docs (3 years)

3382

Total Refs

655

Total Cites (3 years)

162

Citable Docs (3 years)

4,27

Cites/Doc (2 years)

60,39

Ref/Doc

Aims and Scope

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Blood Q1
The Lancet Haematology Q1
Leukemia Q1
Journal of Hematology and Oncology Q1

Best articles

A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer

Acquired immunodeficiency syndrome[mdash ]Associated cancers in Sub-Saharan Africa

Adjuvant bisphosphonate therapy: The future

Advances in the treatment of non[ndash ]small cell lung cancer: Molecular markers take the stage

Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer

Analysis of skeletal-related events in breast cancer and response to therapy

Angiogenesis in multiple myeloma

Angiogenesis-dependent diseases

Anticancer therapy targeting the erbB family of receptor tyrosine kinases

Approaches to preclinical screening of antiangiogenic agents

Assessing Decisional Capacity in the Elderly

Bisphosphonates in oncology: Breast cancer and beyond

SHOW MORE ARTICLES

Bisphosphonates in the prevention of bone metastases: Current evidence

Bladder cancer in Africa: Update

Bone marrow angiogenesis in patients with active multiple myeloma

Bone metastases: Approaches to management

Cancer immunotherapy with natural killer cells

Cancer in older persons: an international issue in an aging world

Cancer-induced systemic myeloid dysfunction: Implications for treatment and a novel nanoparticle approach for its correction

Cancer: A reality in the emerging world

Cardiac toxicity of trastuzumab (herceptin): Implications for the design of adjuvant trials

Cervical cancer in Latin America

Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non[ndash ]small cell lung cancer

Chemotherapy for the treatment of oligodendroglial tumors

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.